NCT05336656
- Conditions
- ARDS, COVID-19, Chemically-Induced Disorders, +20 more
- Locations
-
- Wilkes University Wilkes-Barre, Pennsylvania, United States
Clinical trial condition
Coronaviridae Infections
Explore clinical trials studying Coronaviridae Infections. Study availability and eligibility vary by location and protocol.
5,130 public trials
292 recruiting studies
Coronaviridae Infections trial results
NCT04772820
- Conditions
- Anxiety, Anxiety Disorders, Behavior, +23 more
- Locations
-
- University of Maryland School of Medicine Baltimore, Maryland, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
NCT04516850
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
- Locations
-
- Oncology Institute of Southern Switzerland (IOSI) Bellinzona, Switzerland
- Clinica Luganese Moncucco Lugano, Switzerland
NCT05109598
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
- Locations
-
- Hunan Provincial Center for Disease Control and Prevention Changsha, Hunan, China
NCT05381714
- Conditions
- Behavior, COVID-19, Coronaviridae Infections, +16 more
- Locations
-
- Karabuk University Karabük, Turkey (Türkiye)
Completed
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
NCT04883177
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +13 more
- Locations
-
- The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- Beijing You'an Hospital Beijing, Beijing Municipality, China
- Chongqing Fuling Central Hospital Chongqing, Chongqing Municipality, China
- The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
Completed
The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants
NCT05829551
- Conditions
- COVID-19, COVID-19 (Coronavirus Disease 2019), Coronaviridae Infections, +10 more
- Locations
-
- The First Hospital of Jilin University Jilin City, China
Completed
Immunogenicity and Safety Study of Recombinant Two-Component COVID-19 Vaccine (CHO Cell)(ReCOV)
NCT05323435
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
- Locations
-
- AI Kuwait Hospital Dubai, United Arab Emirates
NCT05050474
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
- Locations
-
- Guangdong Provincial Center for Disease Control and Prevention Guangzhou, Guangdong, China
NCT04961359
- Conditions
- Coronaviridae Infections, Coronavirus, Coronavirus Infections, +4 more
- Locations
-
- Hunan Provincial Center for Disease Control and Prevention Changsha, Hunan, China